Global Gastrointestinal Bleeding Treatment Devices Market Report 2021 Featuring CONMED, Boston Scientific, US Medical Innovations, Ovesco Endoscopy AG, Olympus, Cook Medical, Steris, and Pfizer - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Gastrointestinal Bleeding Treatment Devices Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

The global gastrointestinal bleeding treatment devices market is expected to grow from $682.30 million in 2020 to $722.37 million in 2021 at a compound annual growth rate (CAGR) of 5.9%. The market is expected to reach $889.11 million in 2025 at a CAGR of 5.3%.

Major players in the gastrointestinal bleeding treatment devices market are CONMED, Boston Scientific Corporation, US Medical Innovations, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris Plc, and Pfizer Inc.

The gastrointestinal bleeding treatment devices market consists of sales of gastrointestinal bleeding treatment devices and equipment for gastrointestinal bleeding. Gastrointestinal (GI) bleeding is a sign of an illness in which the gastrointestinal system bleeds.

The main type of products used in gastrointestinal bleeding treatment devices market are endoscopic mechanical devices, endoscopic thermal devices, and others. Endoscopic mechanical devices are used in the management of GI arterial bleeding. These include hemostatic clips, also known as through-the-scope (TTS) clips, endoscopic detachable snare ligation (EDSL) devices, endoscopic suturing, over-the-scope clips (OTSC) and will be reviewed for their technology use and clinical application.

The gastrointestinal bleeding treatment devices market is also segmented by GI tract division into the lower GI tract and upper GI tract and is used in hospitals or clinics, ambulatory surgical centers, others.

The increasing product approvals are the key trend gaining popularity in the gastrointestinal bleeding treatment devices market. Key players in the market are focusing on product approvals to maintain a comparative advantage over competitors in the industry.

For example, in February 2021, EndoClot Plus Inc., a US-based company developing medical devices to meet the needs of the GI professional announced U.S. Food and Drug Administration (FDA) approval for EndoClot Polysaccharide Hemostatic System (EndoClot PHS), which is an advanced product that will assist Gastroenterologists to stop bleeding quickly and effectively. EndoClot PHS is a one-time-use device that consists of a starch-based powder hemostat that is applied directly to the bleeding location using a flexible endoscope.

In January 2021, Olympus Corporation, a Japan-based company offering solutions for effective treatment of gastrointestinal bleeding announced a collaboration with Hitachi Ltd for five-year. Under this collaboration, the companies will work together to develop Endoscopic Ultrasound Systems (EUS), which are used to treat digestive diseases and assess the stage of cancer in the bronchus, liver, pancreas as well as in minimally invasive care, thereby contributing to medical treatment. Hitachi Ltd is a Japanese multinational conglomerate company offering gastrointestinal diagnoses solutions.

The rise in the incidences of upper gastrointestinal bleeding is likely to contribute to the growth of the gastrointestinal bleeding treatment devices market during the forecast period.

Key Topics Covered:

1. Executive Summary

2. Gastrointestinal Bleeding Treatment Devices Market Characteristics

3. Gastrointestinal Bleeding Treatment Devices Market Trends and Strategies

4. Impact Of COVID-19 On Gastrointestinal Bleeding Treatment

5. Gastrointestinal Bleeding Treatment Devices Market Size and Growth

5.1. Global Gastrointestinal Bleeding Treatment Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Gastrointestinal Bleeding Treatment Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Gastrointestinal Bleeding Treatment Devices Market Segmentation

6.1. Global Gastrointestinal Bleeding Treatment Devices Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Endoscopic Mechanical Devices
• Endoscopic thermal Devices
• Others

6.2. Global Gastrointestinal Bleeding Treatment Devices Market, Segmentation by GI Tract Division, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Upper GI Tract
• Lower GI Tract

6.3. Global Gastrointestinal Bleeding Treatment Devices Market, Segmentation by End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Hospitals Or Clinics
• Ambulatory Surgical Centers
• Others

7. Gastrointestinal Bleeding Treatment Devices Market Regional and Country Analysis

7.1. Global Gastrointestinal Bleeding Treatment Devices Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Gastrointestinal Bleeding Treatment Devices Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

• CONMED
• Boston Scientific Corporation
• US Medical Innovations
• Ovesco Endoscopy AG
• Olympus Corporation
• Cook Medical
• Erbe Elektromedizin GmbH
• Steris plc
• Pfizer Inc

For more information about this report visit https://www.researchandmarkets.com/r/iapi1l

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900